Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Children with Advanced Acute Leukemia with Fludarabine-, Busulfan-, and Melphalan-Based Conditioning-Reference-Cited by-同舟云学术

Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Children with Advanced Acute Leukemia with Fludarabine-, Busulfan-, and Melphalan-Based Conditioning

Published:2016-03 Issue:3 Volume:22 Page:499-504
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Jaiswal Sarita Rani,Chakrabarti Aditi,Chatterjee Sumita,Bhargava Sneh,Ray Kunal,O'Donnell Paul,Chakrabarti Suparno

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference34 articles.

1. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure;Duval;J Clin Oncol,2010

3. Treatment of high-risk acute leukemia with T-cell–depleted stem cells from related donors with one fully mismatched HLA haplotype;Aversa;N Engl J Med,1998

4. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide;Luznik;Biol Blood Marrow Transplant,2008

5. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide;O'Donnell;Biol Blood Marrow Transplant,2002

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymeric nanoparticles as delivery vehicles for targeted delivery of chemotherapy drug fludarabine to treat hematological cancers;Inorganic Chemistry Communications;2024-09

3. Donor Selection for Adults and Pediatrics;The EBMT Handbook;2024

4. Improving Outcomes with Haploidentical Stem Cell Transplantation [HaploSCT] in Children Using Post-transplant Cyclophosphamide: a Single Center Experience;Indian Journal of Hematology and Blood Transfusion;2023-09-28

5. Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias;Blood Advances;2023-09-26